Expression of CD44 in Saliva among Group of Smoker Patients with Oral Squamous Cell Carcinoma

Mahdi Yacoob Kzar
Authors Emails are requested on demand or by logging in
Keywords : OSCC, CD44, saliva, smoking
Medical Journal of Babylon  13:3 , 2016 doi:1812-156X-13-3
Published :25 December 2016


The (CD44) biomarker is considered as one candidate molecular marker for detection of head and neck squamous cell carcinoma, it islisted as adhesion molecules. This protein has many functions and considered as multistructural cell surface protein which involved different pathological events. The over-expression of CD44 wasdetected in different cancers in human, including oral squamous cell carcinoma (OSCC). Therefore this study designed to evaluate the role of CD44 in OSCC, quantified in stimulated saliva, beside its correlation with smoking.This case-control study composed of 30 patients with oral squamous cell carcinoma who were smokers, and other 60 control persons for comparison: 30 subjects of them were smoking and others were free of smoking. CD44 was assessed by ELISA technique, in stimulated saliva collected from all groups.The result of this study show thatsalivary CD44 protein level significantly higher in smoker patients with oral squamous cell carcinoma in comparism to smoker and non-smoker control healthy persons, thus the CD44 protein have an important role, as a non-invasive way, in the early diagnosis and monitoring of oral squamous cell carcinoma patients.


The CD44 proteinis considered as adhesion molecules. This type of protein can be released in soluble form through the proteases and can be evaluate in normal circulation. This protein has many functions including cell proliferation, differentiation and other pathological events. These biological properties are essential to the physiological powerful functions of normal cells, while from the other hand they are associated with the pathogenic actions of tumor cells [1]. The circulating levels of sCD44 can be correlate with metastases in some and it is linked to intracytoplasmic signaling pathways and various trans membrane such as those involving epidermal growth factor receptor and others. The interaction between the CD44 and these receptor-mediated signaling pathways were revealed to promote various tumor progression activities that including growth, migration, invasion, and metastasis of tumor cell [2].There is unusual expression of CD44 variantshigh risk precancerous and cancerous lesions was reported by Goodison and Tarin [3]. The experimental research done in animals showing that the targeting of CD44 by CD44-soluble proteins and antisense beside antibodiesinhibit the malignant activities of many types of tumor and emphasizing the therapeutic way of the anti- protein agent. The production of anti CD44 tumor specific agents may be a truthful therapeutic approach, this ismay be related to the alternative splicing and post-translational modifications that releasing different CD44 sequences which including tumorspecific sequence [1]. The expression of this protein in OSCC has demonstrated some analytical influence[4]. The earlier research found that the decreased in the expression of CD44 protein was a significant predictor of poor prognosis in most OSCC studies [5], but many other studies showing thata poor prognosis in OSCC associated with strong expression of this protein[4]. This difference in the results may be due to the absence of standardization in research regarding this agent, particularly in relation to the anatomical region. Kokkoet al[6] found that there is a significant differences regarding the expression of this protein and its prognostic influence regarding the anatomical positionsin the head and neck area. The CD44protein family consist of a standard member of CD44 (CD44s) and other alternative variants (CD44v), it is currently becoming evident that differences in the oral squamous cell carcinoma ability to recurrence, loco regional metastasis, in addition to radiation resistance of its malignant cells, this may be due to the over expression of a specific CD44 isoform [7]. The decrease expression of this protein on tumor cells was significantlycorrelated with poor prognosis in squamous cell carcinoma of tongue, from other sidethere is an absence of protein variant expression was associated with a lowest survival period in squamous cell carcinoma of the lip[8]. There is an increased immune expression of the variant 9 of this protein alternative splice isoform along with a loss of other variant wassignificantlyassociated with a poor picture in oral squamous cell carcinoma clinically, while in the other cases the over expression of CD44v 3 and CD44v 6 appears to show the cellular invasiveness which leads to the elevated aggressiveness of some oral tumors specifically OSCCs invasiveness [9], this given that these different isoforms are associated withlymph node metastasis and resistance to chemotherapy[10].

Materials and methods

The present study included 30 patients having oral squamous cell carcinoma who were smokers and those patients were diagnosed with OSCC and not subjected to any type of treatment regarding this disease. for comparison, 30 apparently healthy smokers and another 30 non-smokers were enrolled in this study. Control subjects were selected in such a way to be matched with age and gender of the patients. Patients age was ranging from 50 to 70 years, included (13) females and (17) males. The study was conducted in AL-HillaTeaching Hospitals in Babylon city. The study was held from May 2015 through February 2016.A sample of stimulated saliva (800µL) was obtainedfrom each patient and control subjects between 8:00 am and 11:00 am. Saliva was stored at -80°C till the time of analysis. The expression of CD44 protein was assessed by ELISA technique.The concentration of protein is measured in pg/ml. This ELISA kit use Sandawich -ELISA. The micro ELISA plate introduced in the kit is precoated with an antibody that specific for this protein.
    Statistical analysis was performed using SPSS version 10.Because they are a non-normally distributed variables, the comparison of median of CD44 concentration among groups was done using the non-parametric Kruskal Wallis test and Mann Whitney U test. P-value was considered significant when it was less than or equal to 0.05 and highly significantwhen it was less than or equal to 0.001.


The median values of sCD44 in all groups are showing in table 1, Figure 1, the highest resultswere found among smokers patients with oral squamous cell carcinoma, followed by non-smoker group OSCC while the lowest values was reported by the smoker group without OSCC. The mean and standard deviation with minimum and maximum values is illustrated in the Table 1. The flour of the mouth was the most common site of the oral squamous cell carcinoma.Figure 1 shows different locations of squamous cell carcinoma in this study.


The present study showed a statistically significantly higher expression of salivary CD44 in patients with OSCC than non-smoker control subjects. In accordance with present study Dalia et al [11]stated that there was a highly significant difference in the mean value of salivary sCD44 level between control group and the oral squamous cell carcinoma groups[12]. The smoking increases salivary protein level in the saliva, this was showing through single linear regression analysis test, between smoking and salivary CD44 protein. The participation of CD44 in the pathogenesis of OSCC may be explained by that this proteinis a complex family composed of molecules, associatedwith aggressive malignancies and cancer stem cells. In another word, the role of the protein variants in tumor progression and treatment resistance is not clear[12], but this protein has been reported to be involved with tumor growth and metastasis and has implicated as a marker oral squamous cell carcinoma.However, the prognostic value ofCD44 still remains controversial. Expression of CD44, a transmembranehyaluronan-binding glyco-proteinis variably considered to have prognosticsignificance for different oral cancers, including oral squamous cell carcinoma [13].But on other side Jianqianget al[14] stated that no clear association was revealed between protein expression and oral squamous cell carcinoma. On the contrary Performing single linear regression analysis in the present study between sCD44 and smoking revealed a positive significant correlation which is in agreement with GhallabandShaker [15] who investigated salivary CD44 level in smoker and non-smoker subjects, with no carcinoma, and concluded a significantly higher level among smokers, in accordance with the results of the present study. The increasing the CD44 level in the saliva of patients with OSCC can be utilized as a non-invasive alternative for early diagnosis of suspicious oral lesions in smoker patients, beside that a target therapy, as stated by Spiegel bergetal[12], can be investigated as a form of treatment to stop tumor progression.


Salivary sCD44 protein can serve as a non-invasive way and can be used as an additive way to the biopsy method that aid in the diagnosis of oral squamous cell carcinoma patient and used in follow up monitoring for those patients.


1.Wang CJ, Zhou ZG, Wang L, et al. Clinico-pathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers. 2009;26(1):27-34.
2.O Hara, J. and P. Bradley,. Head and Neck Cancer: a screening strategy. ClinOtolaryngol., 2002: 27: 133-4.
3.Goodison, S. and D. Tarin,. Clinical implications of anomalous CD44 gene expression in neoplasia. Front. Biosci., 1998. 3: 89-109.
4.Oliveira LR, Oliveira-Costa JP, Araujo IM, Soave DF, Zanetti JS, Soares FA, et al. Cancer stem cell immunophenotypes in oral squamous cell carcinoma. J Oral Pathol Med. 2011;40:135-42.
5.Lindquist D, Ahrlund-Richter A, Tarjon M, Tot T, Dalianis T. Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res. 2012;32(1):153-161.
6.Kokko, L.L., Hurme, S., Maula, S.M., Alanen, K., Grenman, R., Kinnunen, I. and Ventela, S. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncol. 2011, 47, 510-516.
7.Trapasso S, Allegra E. Role of CD44 as marker of cancer stem cells in head and neck cancer. 2012 (6): 379-383.
8.Garc?a-Montesinos-PereaB,Val-Bernal JF, Saiz-Bustillo R. Epidermoid carcinoma of the lip: an immunohistochemical study. 2005 Med Oral Patol Oral Cir Bucal 10: 454-461.
9.Bourguignon LY. Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions. Am J Pathol. 2014;184(7):1912-1919.
10.Sterz CM, Kulle C, Dakic B, Makarova G, Bottcher M, Bette M, et al. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Oral Oncology. 2010;46:116-122.
11.Dalia M. Ghalwash, Khaled El Gaaly, Fat heya M. Zahran, Olfat Shaker, Hossam A. El-Fol. The diagnostic and prognostic value of salivary sCD44 level determination in oral malignant and potentially premalignant lesions Advances in Environmental Biology, 2012:6(1): 302-310.
12.Spiegelberg D., Kuku G., Selvaraju R., Nestor M. Characterization of CD44 variant expression in head and neck squamous cell carcinomas. Tumour Biol. 2014;35:2053–2062.
13.AbiramiRajarajan, Angela Stokes, Balvinder K. Bloor, et al January .2012. Volume 7, Issue 1, 28776.
14.JiapingXue, Yang S., Seng S. Mechanisms of cancer induction by tobacco-specific NNK and NNN. Cancers. 2014;6:1138–1156.
15.Ghallab N, Shaker O. Salivary-soluble CD44 levels in smokers and non-smokers with chronic periodontitis: a pilot study. J Periodontol. 2010;81(5):710-717.

The complete article is available as a PDF File that is freely accessible. The fully formatted HTML version can be viewed as HTML Page.

Medical Journal of Babylon

volume 13 : 3

Share |

Viewing Options

Download Abstract File
( 59 KB )

Related literature

Cited By
Google Blog Search
Other Articles by authors

Related articles/pages

On Google
On Google Scholar
On UOBabylon Rep

User Interaction

362  Users accessed this article in 1 year past
Last Access was at
20/05/2018 09:41:10